Walleye Capital LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,604,929
+12.9%
314,292
+149.1%
0.01%
-18.2%
Q2 2023$3,193,818
-65.4%
126,188
-56.0%
0.01%
-92.0%
Q1 2023$9,230,162
-1.7%
286,562
-43.7%
0.14%
-19.3%
Q4 2022$9,390,510
-33.5%
508,695
-2.7%
0.17%
-36.7%
Q3 2022$14,122,000
+119.8%
523,045
+12.5%
0.27%
+52.5%
Q2 2022$6,426,000
-34.8%
464,970
-8.1%
0.18%
-33.0%
Q1 2022$9,861,000
+69.1%
505,701
+41.6%
0.26%
+45.9%
Q4 2021$5,830,000
+284.1%
357,237
+555.8%
0.18%
+320.9%
Q3 2021$1,518,000
-52.1%
54,477
-49.0%
0.04%
-60.2%
Q2 2021$3,167,000
+61.3%
106,859
+52.1%
0.11%
-5.3%
Q1 2021$1,963,000
-2.9%
70,249
-1.6%
0.11%
-15.6%
Q4 2020$2,022,000
+354.4%
71,365
+108.1%
0.14%
+175.5%
Q2 2019$445,000
+1.6%
34,300
+94.4%
0.05%
-76.0%
Q3 2018$438,00017,6440.20%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders